Osel Inc
  • ABOUT
  • OUR SCIENCE
  • WOMEN’S HEALTH
  • ONCOLOGY
  • PIPELINE
  • PUBLICATIONS
  • NEWS
  • CONTACT
  • COMMONLY ASKED QUESTIONS
Select Page

Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women.

by Osel | Jan 20, 2007 | LACTIN-V CLINICAL

Czaja CA, Stapleton AE, Yarova-Yarovaya Y, Stamm WE. Infect Dis Obstet Gynecol. 2007;2007:35387. doi: 10.1155/2007/35387.     Synopsis: L. crispatus CTV-05 appears to be safe and well tolerated when given as a vaginal suppository to healthy women with a...
Next Entries »

Explore Publications

  • LACTIN-V
  • CBM588
  • MUCOCEPT